FRO treatment of acne vulgaris is predominantly associated with its exceptional anti-sebum production ability via the regulation of SREBP-1 and modulation of inflammation and oxidants via the NF-κB and STAT signaling pathways. The gene discussed is NFKB1; the disease is acne.